By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today said that it and partner Asuragen have achieved CE marking and launched in Europe their BCR/ABL1 Quant Test, which is used to monitor treatment of chronic myeloid leukemia patients. Asuragen manufactures the test, and Life Technologies exclusively distributes the test, which runs on the Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.